Sildenafil in Heart Failure With Reactive Pulmonary Hypertension
Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Sildenafil 20mg taken three times a day is
effective in the treatment of Heart Failure with Reactive Pulmonary Hypertension. This is a
double-blind, placebo controlled trial.